Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome

Clinical Endocrinology

Volumn 57, Issue 6, 2002, Pages 827-831

  Alexander, Erik K ^a   Robinson, Malcolm ^a   Staniec, Maryjane ^a   Dluhy, Robert G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CARNATION INSTANT BREAKFAST; FATTY ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; ERYTHEMA CHRONICUM MIGRANS; GLUCAGONOMA; HUMAN; INFUSION; LONG TERM CARE; MALE; MORBIDITY; NECROLYTIC MIGRATORY ERYTHEMA; PRIORITY JOURNAL; RASH; TUMOR GROWTH; BLOOD; ERYTHEMA; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PALLIATIVE THERAPY; PANCREAS TUMOR; SYNDROME; TIME;

AMINO ACIDS; ERYTHEMA; FATTY ACIDS; GLUCAGONOMA; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PALLIATIVE CARE; PANCREATIC NEOPLASMS; SYNDROME; TIME FACTORS;

EID: 0041589126     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01660.x     Document Type: Article

References (12)

1. Almdal, T.P., Heindorff, H., Bardram, L. & Vilstrup, H. (1990) Increased amino acid clearance and urea synthesis in a patient with glucagonoma. Gut, 31, 946-948.
2. Becker, S.W. & Rothman, S. (1942) Cutaneous manifestations of internal malignant tumors. Archives of Dermatology and Syphilogy, 45, 1069.
3. Bewley, A.P., Ross, J.S., Bunker, C.B. & Staughton, R.C. (1996) Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema. British Journal of Dermatology, 134, 1101-1104.
4. Blackford, S., Wright, S. & Roberts, D.L. (1991) Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids. British Journal of Dermatology, 125, 460-462.
5. Boden, G., Ryan, I.G., Eisenschmid, B.L., Shelmet, J.J. & Owen, O.E. (1986) Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. N Engl J Med, 314, 1686-1689.
6. Norton, J.A.K.C., Schiebinger, R., Gorschboth, C. & Brennan, M.F. (1979) Amino acid deficiency and the skin rash associated with glucagonoma. Annals of Internal Medicine, 91, 213-215.
7. Rosenbaum, A., Flourie, B., Chagnon, S., Blery, M. & Modigliani, R. (1989) Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature. Digestion, 42, 116-120.
8. Shepherd, M.E., Raimer, S.S., Tyring, S.K. & Smith, E.B. (1991) Treatment of necrolytic migratory erythema in glucagonoma syndrome. Journal of the American Academy of Dermatology, 25, 925-928.
9. Skogseid, B., Eriksson, B., Lundqvist, G. et al. (1991) Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. Journal of Clinical Endocrinological Metabolism, 73, 281-287.
10. Stacpoole, P.W. (1981) The glucagonoma syndrome: clinical features, diagnosis, and treatment. Endocrine Review, 2, 347-361.
11. Wermers, R.A., Fatourechi, V., Wynne, A.G., Kvols, L.K. & Lloyd, R.V. (1996) The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine, 75, 53-63.
12. Wilkinson, D.S. (1973) Necrolytic migratory erythema with carcinoma of the pancreas. Transactions of the St Johns Hospital Dermatological Society, 59, 244-250.